These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11362873)
41. FDA looks at full approval for d4T. Food and Drug Administration. Posit Aware; 1996; 7(1):7. PubMed ID: 11363131 [TBL] [Abstract][Full Text] [Related]
42. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
43. FDA approves first new class of HIV drugs. Food and Drug Administration. AIDS Alert; 1996 Aug; 11(8):89. PubMed ID: 11363655 [TBL] [Abstract][Full Text] [Related]
44. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration. Schouten JT STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592 [TBL] [Abstract][Full Text] [Related]
46. The growing debate over FDA reform. Food and Drug Administration. Link D GMHC Treat Issues; 1996 Jan; 10(1):1-5. PubMed ID: 11363372 [TBL] [Abstract][Full Text] [Related]
47. Placebo response and antidepressant clinical trial outcome. Khan A; Detke M; Khan SR; Mallinckrodt C J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731 [TBL] [Abstract][Full Text] [Related]
48. FDA reform in Congress: interview with Peter Barton Hutt. Food and Drug Administration. Interview by John S. James. Hutt PB AIDS Treat News; 1996 Apr; (no 245):4-5. PubMed ID: 11363623 [TBL] [Abstract][Full Text] [Related]
49. Philadelphia area AIDS/HIV clinical trials. Crit Path AIDS Proj; 1998; (No 33):35-43. PubMed ID: 11366372 [TBL] [Abstract][Full Text] [Related]
50. Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114 [TBL] [Abstract][Full Text] [Related]
51. Redefining the role of HIV viral load monitoring. MacDougall DS J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):16-21. PubMed ID: 11365083 [TBL] [Abstract][Full Text] [Related]
52. Proving clinical benefit in small, rapid trials: statement to National Task Force on AIDS Drug Development. James JS AIDS Treat News; 1995 Mar; (no 218):4-6. PubMed ID: 11362328 [TBL] [Abstract][Full Text] [Related]
53. Clinical trials for patients with AIDS or HIV infection. Mackie ID CMAJ; 1990 Aug; 143(3):173-4. PubMed ID: 2199008 [No Abstract] [Full Text] [Related]
54. Design of clinical trials for new drugs in animals. Muser RK J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1148-50. PubMed ID: 7216890 [TBL] [Abstract][Full Text] [Related]
55. Lessons from the Concorde trial. Gazzard BG Br J Hosp Med; 1995 Mar 15-Apr 4; 53(6):296. PubMed ID: 7767581 [No Abstract] [Full Text] [Related]
56. Initial treatment for HIV infection. When, why, and with what? Kahn JO Adv Exp Med Biol; 1999; 458():229-37. PubMed ID: 10549395 [No Abstract] [Full Text] [Related]
57. FDA taps anti-emetic for treatment of AIDS complication. RN; 1993 Apr; 56(4):93. PubMed ID: 8386850 [No Abstract] [Full Text] [Related]
59. FDA clears drug trials to combat systemic CMV. AIDS Patient Care STDS; 1997 Aug; 11(4):295-6. PubMed ID: 11361854 [No Abstract] [Full Text] [Related]
60. Focus of new FDA division is AIDS, opportunistic infections. Clin Pharm; 1988 May; 7(5):337. PubMed ID: 3383541 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]